封面
市场调查报告书
商品编码
1386355

麻疹疫苗市场报告:2030 年趋势、预测与竞争分析

Measles Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

麻疹疫苗趋势和预测

预计2024年至2030年全球麻疹疫苗市场将以5.8%的复合年增长率成长。该市场的主要驱动力是麻疹盛行率的增加、免疫计划的扩大以及新型疫苗的持续开发。全球麻疹疫苗市场前景广阔,医院、疫苗接种中心和社区诊所市场蕴藏商机。

麻疹疫苗市场洞察

根据 Lucintel 的预测,预计儿童人口在预测期内将经历最高增长。

预计北美地区在预测期内将出现最高的成长。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去五年发生了哪些併购事件,对产业产生了哪些影响?

目录

第一章执行摘要

第二章全球麻疹疫苗市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球麻疹疫苗市场趋势(2018-2023)与预测(2024-2030)
  • 按类型分類的全球麻疹疫苗市场
    • 流行性腮腺炎、麻疹、德国麻疹疫苗
    • MMR-II活病毒疫苗
  • 全球麻疹疫苗市场按应用
    • 儿童族群
    • 青年人口
    • 成年人口
  • 全球麻疹疫苗市场(依最终用途)
    • 医院
    • 疫苗接种中心
    • 社区诊所

第四章 2018-2030年区域市场趋势及预测分析

  • 全球麻疹疫苗市场区域分布
  • 北美麻疹疫苗市场
  • 欧洲麻疹疫苗市场
  • 亚太麻疹疫苗市场
  • 其他地区麻疹疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球麻疹疫苗市场成长机会
    • 全球麻疹疫苗市场成长机会(按应用)
    • 全球麻疹疫苗市场成长机会(依最终用途)
    • 全球麻疹疫苗市场成长机会(按地区)
  • 全球麻疹疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球麻疹疫苗市场产能
    • 全球麻疹疫苗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • China National Biotech
  • Merck & Company
  • MedImmune Health
  • JC Green Cannabis
  • Bavarian Nordic
  • Sanofi
  • Pfizer
  • Novartis
  • Johnsons & Johnsons
  • Emergent BioSolutions
简介目录

Measles Vaccine Trends and Forecast

The future of the global measles vaccine market looks promising with opportunities in the hospital, vaccination center, and community clinic markets. The global measles vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing incidence of measles, expansion in immunization programs, and continuous development of new vaccines.

A more than 150-page report is developed to help in your business decisions.

Measles Vaccine by Segment

The study includes a forecast for the global measles vaccine by type, application, end use, and region.

Measles Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Mumps Measles Rubella Vaccine
  • Live MMR-II

Measles Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pediatric Population
  • Adolescent Population
  • Adult Population

Measles Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Vaccination Centers
  • Community Clinics

Measles Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Measles Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies measles vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the measles vaccine companies profiled in this report include-

  • China National Biotech
  • Merck & Company
  • Medimmune Health
  • JC Green Cannabis
  • Bavarian Nordic
  • Sanofi
  • Pfizer
  • Novartis
  • Johnsons & Johnsons
  • Emergent Biosolutions

Measles Vaccine Market Insights

Lucintel forecasts that pediatric population is expected to witness highest growth over the forecast period due to rising use of the measles vaccination among these people owing to its increased efficacy.

North America is expected to witness highest growth over the forecast period.

Features of the Global Measles Vaccine Market

Market Size Estimates: Measles vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Measles vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Measles vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the measles vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the measles vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the measles vaccine market size?

Answer: The global measles vaccine market is expected to reach an estimated $xx billion by 2030.

Q.2 What is the growth forecast for measles vaccine market?

Answer: The global measles vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the measles vaccine market?

Answer: The major drivers for this market are growing incidence of measles, expansion in immunization programs, and continuous development of new vaccines.

Q4. What are the major segments for measles vaccine market?

Answer: The future of the measles vaccine market looks promising with opportunities in the hospital, vaccination center, and community clinic markets.

Q5. Who are the key measles vaccine market companies?

Answer: Some of the key measles vaccine companies are as follows:

  • China National Biotech
  • Merck & Company
  • Medimmune Health
  • JC Green Cannabis
  • Bavarian Nordic
  • Sanofi
  • Pfizer
  • Novartis
  • Johnsons & Johnsons
  • Emergent Biosolutions

Q6. Which measles vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that pediatric population is expected to witness highest growth over the forecast period due to rising use of the measles vaccination among these people owing to its increased efficacy.

Q7. In measles vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the measles vaccine market by type (mumps measles rubella vaccine and live mmr-II), application (pediatric population, adolescent population, and adult population), end use (hospitals, vaccination centers, and community clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Measles Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Measles Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Measles Vaccine Market by Type
    • 3.3.1: Mumps Measles Rubella Vaccine
    • 3.3.2: Live MMR-II
  • 3.4: Global Measles Vaccine Market by Application
    • 3.4.1: Pediatric Population
    • 3.4.2: Adolescent Population
    • 3.4.3: Adult Population
  • 3.5: Global Measles Vaccine Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Vaccination Centers
    • 3.5.3: Community Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Measles Vaccine Market by Region
  • 4.2: North American Measles Vaccine Market
    • 4.2.1: North American Measles Vaccine Market by Application: Pediatric Population, Adolescent Population, and Adult Population
    • 4.2.2: North American Measles Vaccine Market by End Use: Hospitals, Vaccination Centers, and Community Clinics
  • 4.3: European Measles Vaccine Market
    • 4.3.1: European Measles Vaccine Market by Application: Pediatric Population, Adolescent Population, and Adult Population
    • 4.3.2: European Measles Vaccine Market by End Use: Hospitals, Vaccination Centers, and Community Clinics
  • 4.4: APAC Measles Vaccine Market
    • 4.4.1: APAC Measles Vaccine Market by Application: Pediatric Population, Adolescent Population, and Adult Population
    • 4.4.2: APAC Measles Vaccine Market by End Use: Hospitals, Vaccination Centers, and Community Clinics
  • 4.5: ROW Measles Vaccine Market
    • 4.5.1: ROW Measles Vaccine Market by Application: Pediatric Population, Adolescent Population, and Adult Population
    • 4.5.2: ROW Measles Vaccine Market by End Use: Hospitals, Vaccination Centers, and Community Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Measles Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Measles Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Measles Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Measles Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Measles Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Measles Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Measles Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: China National Biotech
  • 7.2: Merck & Company
  • 7.3: MedImmune Health
  • 7.4: JC Green Cannabis
  • 7.5: Bavarian Nordic
  • 7.6: Sanofi
  • 7.7: Pfizer
  • 7.8: Novartis
  • 7.9: Johnsons & Johnsons
  • 7.10: Emergent BioSolutions